Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease
These guidelines are presented as a follow-up to the original Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of infliximab in Crohn's disease, published in the Canadian Journal of Gastroenterology (1). The original guidelines represented publications between...
Saved in:
Main Authors: | Remo Panaccione, Richard N Fedorak, Guy Anmais, Charles N Bernstein, Alain Bitton, Ken Croitoru, Robert Enns, Brian Feagan, Marty Fishman, Gordon Greenberg, Anne Griffiths, John K Marshall, Imran Rasul, Daniel Sadowski, Ernest Seidman, Hillary Steinhart, Lloyd Sutherland, Eric Walli, Gary Wild, C Noel Williams, Mary Zachos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2004/670161 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis
by: Remo Panaccione, et al.
Published: (2008-01-01) -
Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease
by: Brian Bressler, et al.
Published: (2015-01-01) -
Refractory Crohn’s Disease of the Vulva Treated with Infliximab: A Case Report
by: Sapna Makhija, et al.
Published: (2007-01-01) -
Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Tumour Necrosis Factor-Alpha Antagonist Therapy in Crohn’s Disease
by: Daniel C Sadowski, et al.
Published: (2009-01-01) -
Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
by: Neeraj Narula, et al.
Published: (2009-01-01)